Understanding May 29 2026 This Week In Cardiology
If you are looking for information about May 29 2026 This Week In Cardiology, you have come to the right place. A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in
Key Takeaways about May 29 2026 This Week In Cardiology
- John Mandrola offers an ACC recap of 5 big trials—Hi-PEITHO, PROTAVI, ORBITA-CTO, CHIPS-BCIS3 and CHAMPION AF This ...
- Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ...
- Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the ...
- Early aortic valve replacement in aortic stenosis, left atrial appendage occlusion in JAMA
- Listener feedback from the DanGer Shock investigators, complete vs staged revascularization, polygenic risk scores, and quality ...
Detailed Analysis of May 29 2026 This Week In Cardiology
Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid ... Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail ... Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the ...
PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA ...
We hope this detailed breakdown of May 29 2026 This Week In Cardiology was helpful.
